Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
MVNT (multinodular and vacuolating neuronal tumor of the cerebrum) is a benign, recently discovered, neuronal lesion, the incidence of which is unknown.
It seems to predominate in the temporal lobes and presents a characteristic MRI appearance: multiple subcortical nodules, developed at the white substance / gray substance junction, of variable size, well limited, in iso-hyposignal T1, hypersignal T2 and hypersignal FLAIR.
The articles describing this entity report the lack of scalability in MRI during patient monitoring, going in the direction of the benignity of the lesion.
The diagnosis sometimes remains uncertain with current MRI sequences, and the patient risks undergoing invasive surgery to remove a lesion that is actually benign. Hence the importance of developing the most precise diagnostic criteria possible. The contribution of advanced MRI techniques, such as ultra-high resolution sequences in the characterization of these lesions, has not yet been studied.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| cerebral MRI | Other | Patients who agree to participate in the study will perform an MRI with ultra high resolution sequences added by the research MRI of control will be done at one year and two years |
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of the proportion of patients with a central T2 / FLAIR hyposignal visible on standard sequences and on ultra-high resolution sequences. | Among the patients with confirmation of the diagnosis of MVNT (Multinodular and Vacuolating Neuronal Tumor) on the characterization MRI | Day 1 |
Not provided
Not provided
Inclusion Criteria:
Patient over 18 years of age
Prospective inclusion of all patients with suspected MVNT on a first exploratory MRI: at least the 2 major criteria associated with at least 1 minor criterion will be required to fit into the definition of suspected MVNT:
Major criteria :
Minor criteria :
Having received informed information about the study and having given express consent to participate in the study
Exclusion Criteria:
Secondary exclusion criteria:
- No characterization MRI done
Not provided
Not provided
Not provided
Patients with suspicion of MVNT during a first exploratory MRI.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Amelie YAVCHITZ, PhD | Contact | 0148036454 | ayavchitz@for.paris | |
| Augustin Lecler | Contact | 0148036401 | alecler@for.paris |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Groupe Hospitalier Pellegrin | Active, not recruiting | Bordeaux | Bordeaux | 33076 | France | |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| CHU Rennes |
| Recruiting |
| Rennes |
| Rennes |
| 35033 |
| France |
|
| CHU de Rouen | Active, not recruiting | Rouen | Rouen | 76000 | France |
| Hôpital Pierre Paul Riquet, CHU Purpan | Active, not recruiting | Toulouse | Toulouse | 31059 | France |
| Fondation A De Rothschild | Recruiting | Paris | 75019 | France |
|
| Centre Hospitalier Lyon Sud | Active, not recruiting | Pierre-Bénite | 69495 | France |
| Hôpital Laennec | Recruiting | Saint-Herblain | 44800 | France |
|